Breastfeeding domeperiodne
Download as DOCX, PDF1 like549 views
This document summarizes a study that examined the relationship between the drug domperidone, which is commonly used off-label to stimulate lactation, and the risk of ventricular arrhythmia and mortality during the postpartum period. The study used a retrospective cohort of over 225,000 women in British Columbia between 2002-2011. It found a possible doubling of the risk of hospitalization for ventricular arrhythmia among those exposed to domperidone, though the results were not statistically significant. Larger studies are needed to confirm any association.
Breastfeeding domeperiodne
- 1. The association between domperidone and ventricular arrhythmia in the postpartum period. Smolina K1 , Mintzes B2 , Hanley GE3 , Oberlander TF4 , Morgan SG5 . Author information 1 School of Population and Public Health,University of British Columbia,Vancouver, BC. [email protected]. 2 Faculty of Pharmacyand Charles Perkins Centre,Universityof Sydney, Australia. 3 Departmentof Obstetrics and Gynaecology, University of British Columbia,Vancouver, BC. 4 Child & Family Research Institute,University of British Columbia,Vancouver, BC. 5 School of Population and Public Health,University of British Columbia,Vancouver, BC. Abstract PURPOSE:The aim of this study is to examine the relationship between domperidone (commonly used off-label for lactation stimulation), ventricular arrhythmia and all-cause mortality during the postpartum period. METHODS: This is a retrospective, population-based cohort study of all women with a live birth between 1 January 2002 and 31 December2011 in British Columbia, Canada. Cox proportional hazards models, yielding hazard ratios (HRs), were used to estimate the risk of hospitalization for ventricular arrhythmia associated with domperidone exposure within six months postpartum. RESULTS:The study population consisted of 225 532 women with 320 351 live births. There was only one death during the six-month postpartum period among the study population, and thus we did not perform any analyses of all-cause mortality. We identified 21 hospitalizations for ventricular arrhythmia. Adjusting for age, smoking and prior history of ventricular arrhythmia and cardiovascular disease, the risk of ventricular arrhythmia hospitalization was approximately double among those exposed to domperidone, but the results were not statistically significant (HR = 2.25, 95%CI 0.84- 6.01). Adjustment for body mass index in the 74% of women for whom it was known further reduced the association (HR = 1.69, 95%CI 0.48-5.96). CONCLUSIONS: We found a possible association between exposure to domperidone and hospitalization for ventricular arrhythmia among a cohort of women who have recently given birth. Future studies are needed to confirm this association. Copyright © 2016 John Wiley & Sons, Ltd.